Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 6.02
-0.29 (-4.52%)
Sep 11, 2026, 4:08 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 2.55 billion as of September 11, 2026. Its market cap has decreased by -57.70% in one year.
Market Cap
2.55B
Enterprise Value
1.43B
Revenue
296.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.02
ChartMarket Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 2.55B, a decrease of -56.48%. That is a compound annual growth rate of -22.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 2.55B | -55.13% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.69B |
| Mirxes Holding Company | 3.66B |
| HJ Science | 3.31B |
| Jiangsu Recbio Technology | 3.08B |
| BioDlink International Company | 2.91B |
| Clover Biopharmaceuticals | 2.84B |
| Medtide | 2.84B |
| Viva Biotech Holdings | 2.73B |